Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

992 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study.
Alcaraz A, González-López R, Morote J, de la Piedra C, Meseguer C, Esteban E, Climent M, González-Gragera B, Alvarez-Ossorio JL, Chirivella I, Mellado B, Lara PC, Vázquez F, Contreras JA, Carles J, Murias A, Calderero V, Comet-Batlle J, González-Del Alba A, León-Mateos L, Mañas A, Segarra J, Lassa A, González-Enguita C, Méndez MJ, Samper P, Unda M, Mahillo-Fernández I, Bellmunt J; TUGAMO GROUP. Alcaraz A, et al. Among authors: vazquez f. Br J Cancer. 2013 Jul 9;109(1):121-30. doi: 10.1038/bjc.2013.272. Epub 2013 Jun 25. Br J Cancer. 2013. PMID: 23799855 Free PMC article.
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study.
de la Piedra C, Alcaraz A, Bellmunt J, Meseguer C, Gómez-Caamano A, Ribal MJ, Vázquez F, Anido U, Samper P, Esteban E, Álvarez-Ossorio JL, Lara PC, San José LA, Contreras JA, del Alba AG, González-Gragera B, Tabernero AJ, González-Enguita C, Fernández JM, García-Escudero A, Gómez-Veiga F, Méndez MJ, Segarra J, Virizuela JA, Carles J, Lassa A, Calderero V, Constela M, Delgado D, Mañas A, Murias A, Reynes G, Rodriguez B, Rubio G, Sánchez E, Unda M, Solsona E, Martínez-Javaloyas JM, Comet-Batlle J, Quicios C, Martín-Fernández M, Mahillo-Fernández I, Morote J. de la Piedra C, et al. Among authors: vazquez f. Br J Cancer. 2013 Jun 25;108(12):2565-72. doi: 10.1038/bjc.2013.270. Epub 2013 May 30. Br J Cancer. 2013. PMID: 23722472 Free PMC article. Clinical Trial.
Cognitive function in patients on androgen suppression: A prospective, multicentric study.
Morote J, Tabernero ÁJ, Álvarez-Ossorio JL, Ciria JP, Domínguez-Escrig JL, Vázquez F, Angulo J, López FJ, de La Iglesia R, Romero J; Grupo de investigación ANAMEM. Morote J, et al. Among authors: vazquez f. Actas Urol Esp (Engl Ed). 2018 Mar;42(2):114-120. doi: 10.1016/j.acuro.2017.04.007. Epub 2017 Nov 6. Actas Urol Esp (Engl Ed). 2018. PMID: 29102054 English, Spanish.
A randomized phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN).
Bellmunt J, Kerst JM, Vázquez F, Morales-Barrera R, Grande E, Medina A, González Graguera MB, Rubio G, Anido U, Fernández Calvo O, González-Billalabeitia E, Van den Eertwegh AJM, Pujol E, Perez-Gracia JL, González Larriba JL, Collado R, Los M, Maciá S, De Wit R; SOGUG and DUOS. Bellmunt J, et al. Among authors: vazquez f. Ann Oncol. 2017 Jul 1;28(7):1517-1522. doi: 10.1093/annonc/mdx186. Ann Oncol. 2017. PMID: 28419193 Free article. Clinical Trial.
National recommendations document on the follow-up of patients with renal cell carcinoma.
Juárez Á, Álvarez-Ossorio JL, Carballido J, Llarena R, Medina R, Moreno J, Sánchez E, Vázquez F, Cózar JM. Juárez Á, et al. Among authors: vazquez f. Actas Urol Esp (Engl Ed). 2018 Jul-Aug;42(6):381-388. doi: 10.1016/j.acuro.2017.11.004. Epub 2018 Feb 2. Actas Urol Esp (Engl Ed). 2018. PMID: 29398094 English, Spanish.
Cognitive Function in Patients With Prostate Cancer Receiving Luteinizing Hormone-Releasing Hormone Analogues: A Prospective, Observational, Multicenter Study.
Morote J, Tabernero ÁJ, Álvarez Ossorio JL, Ciria JP, Domínguez-Escrig JL, Vázquez F, Angulo J, López FJ, de La Iglesia R, Romero J; ANAMEM Investigator Group. Morote J, et al. Among authors: vazquez f. Int J Radiat Oncol Biol Phys. 2017 Jul 1;98(3):590-594. doi: 10.1016/j.ijrobp.2017.02.219. Epub 2017 Mar 6. Int J Radiat Oncol Biol Phys. 2017. PMID: 28581399
Androgen deprivation therapy in patients with localized disease: Comparison with curative intent treatments and time to castration resistance. Results of the Spanish Prostate Cancer Registry.
Garcia-Rodriguez J, Fernandez-Gomez JM, Cozar JM, Miñana B, Gomez-Veiga F, Rodriguez-Antolin A; en representación del Grupo Español de Cáncer de Próstata (GESCAP); En representación del del Grupo Español de Cáncer de Próstata (GESCAP). Garcia-Rodriguez J, et al. Actas Urol Esp (Engl Ed). 2020 Apr;44(3):156-163. doi: 10.1016/j.acuro.2019.06.006. Epub 2020 Feb 26. Actas Urol Esp (Engl Ed). 2020. PMID: 32113829 English, Spanish.
992 results